CD14 gene promoter polymorphism in different clinical forms of tuberculosis. (Q47899325)

6 February 2018

title

CD14 gene promoter polymorphism in different clinical forms of tuberculosis. (English)

1 reference

6 February 2018

1 reference

Eugenia Pacheco

1

1 reference

6 February 2018

Carolina Fonseca

2

1 reference

6 February 2018

Carlos Montes

3

1 reference

6 February 2018

Jovanny Zabaleta

4

1 reference

6 February 2018

Luis F García

5

1 reference

6 February 2018

Mauricio A Arias

6

1 reference

6 February 2018

publication date

1 April 2004

1 reference

6 February 2018

FEMS Immunology and Medical Microbiology

published in

1 reference

6 February 2018

volume

40

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

207-213

1 reference

6 February 2018

A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

Immunology of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

CD14 is a pattern recognition receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

CD14 expression and production by human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Synthesis and surface expression of CD14 by human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Soluble CD14 participates in the response of cells to lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Serum CD14 levels in poly traumatized and severely burned patients

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Increased Circulating Soluble Cd14 Is Associated With High Mortality In Gram-Negative Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Increased levels of soluble CD14 in sera of periodontitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

CCAAT/enhancer-binding protein activates the CD14 promoter and mediates transforming growth factor beta signaling in monocyte development

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

A Polymorphism in the CD14 Gene is Associated with Crohn Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Promoter region polymorphism of the CD14 gene (C-159T) is not associated with psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Adenosine deaminase in body fluids: A useful diagnostic tool in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Genetic demography of Antioquia (Colombia) and the Central Valley of Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Evaluation of the CD14 C-159 T polymorphism in the German Multicenter Allergy Study cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Lack of association between the -260 C-->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

CD14: an example of gene by environment interaction in allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

Association of the CD14 gene -159C polymorphism with progression of IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900369-9

7 January 2021

10.1016/S0928-8244(03)00369-9

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

15039096

1 reference

6 February 2018